<SEC-DOCUMENT>0001104659-25-106789-index.html : 20251105
<SEC-HEADER>0001104659-25-106789.hdr.sgml : 20251105
<ACCEPTANCE-DATETIME>20251105103131
ACCESSION NUMBER:		0001104659-25-106789
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251105
DATE AS OF CHANGE:		20251105

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neuphoria Therapeutics Inc.
		CENTRAL INDEX KEY:			0001191070
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93208
		FILM NUMBER:		251452367

	BUSINESS ADDRESS:	
		STREET 1:		100 SUMMIT DR
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803
		BUSINESS PHONE:		781-439-5551

	MAIL ADDRESS:	
		STREET 1:		100 SUMMIT DR
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIONOMICS LIMITED/FI
		DATE OF NAME CHANGE:	20020920

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coastlands Capital LP
		CENTRAL INDEX KEY:			0002068530
		ORGANIZATION NAME:           	
		EIN:				333553930
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		601 CALIFORNIA STREET, SUITE 1210
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94108
		BUSINESS PHONE:		(415) 249-1280

	MAIL ADDRESS:	
		STREET 1:		601 CALIFORNIA STREET, SUITE 1210
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94108
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2530303d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: tm2530303d1_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>